Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Croatia

Research and Innovation Action · Running

EU4MEDTECH European Framework for Advanced Medical Technology Evaluation and Follow-up

Coordinator
Sveuciliste U Splitu Medicinski Fakultet, Croatia
Runs
1 December 2024 to 30 November 2028
Status
Running
EU funding
€7.7m
Total cost
€7.7m
Partners
15 organisations in 10 countries
Type
Research and Innovation Action
Grant agreement
101191683

What the project is doing

In the project's own words, from its summary on CORDIS.

The Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) have been introduced, replacing previous MD and IVD Directives to strengthen the EU regulatory framework, ensuring the highest levels of patient safety and smooth functioning of the single market for these products. Yet, this regulatory update comes with challenges arising from the increased regulatory burden and strain across various actors in the EU HealthTech value chain.

To overcome these hurdles, in EU4MEDTECH, we will co-create (with an a-priori established Stakeholder Forum) and validate “EU4MEDTECH framework”, a versatile and life cycle-oriented set of methodological approaches, standardised models, and multi-domain criteria for the generation and evaluation of clinical and performance evidence of high-risk, innovative MDs and IVDs across pre-/post-market stages. An interactive, cloud-based digital platform will be designed and developed to operationalise EU4MEDTECH framework.

The latter will include further features, such as a regulatory communication channel, a global regulatory search feature, a user training feature for EUDAMED stakeholders and a repository. EU4MEDTECH framework and recommendations for new common specifications, once integrated into the digital platform, will be evaluated within 3 different Use Cases (UCs). UC1 will focus on class III and implantable MDs, UC2 will target class C/D IVDs, whereas UC3 will focus on MD and IVD software (MDSW/IVDSW) and other highly innovative devices. 3 clinical studies will be performed in the context of UC3.

Similarly, the digital platform will be evaluated through a Proof-of-Concept (PoC) study. Key MedTech stakeholders will be engaged in co-design throughout the project activities. A comprehensive exploitation roadmap will be developed to ensure that project results are widely and equitably adopted, scalable, and sustainable.

Topics

Who is involved

OrganisationCityCountryRole
Sveuciliste U Splitu Medicinski FakultetSplitCroatiaCoordinator
Stelar Security Technology Law Research UG (haftungsbeschrankt) GmbHHamburgGermanyParticipant
Enosi Asthenon ElladasAthinaGreeceParticipant
Fundacio EurecatCerdanyola Del Valles (Barcelona)SpainParticipant
Clinipower Finland OySavonlinnaFinlandParticipant
Hus-YhtymaHelsinkiFinlandParticipant
Sgs Fimko OyHelsinkiFinlandParticipant
Echr Drustvo S Ogranicenom Odgovornoscu Za UslugeSplitCroatiaParticipant
Klinicki Bolnicki Centar SplitSplitCroatiaParticipant
Hun-Ren Szamitastechnikai Es Automatizalasi KutatointezetBudapestHungaryParticipant
Hun-Ren Szamitastechnikai Es Automatizalasi KutatointezetBudapestHungaryParticipant
University of GalwayGalwayIrelandParticipant
Norges Teknisk-Naturvitenskapelige Universitet NTNUTrondheimNorwayParticipant
Instituto Pedro Nunes Associacao Para a Inovacao E Desenvolvimento Em Ciencia E TecnologiaCoimbraPortugalParticipant
Univerzita Komenskeho V BratislaveBratislava 1SlovakiaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI